Stock Analysis:: Adamis Pharmaceuticals Corporation, (NASDAQ: ADMP)

 

On Monday, November 16, 2020, the Company, Adamis Pharmaceuticals Corporation, ADMP stock construct a change of -41.22 percent (Loss) in a total of its share price and having its trading value $0.4, which belongs to Healthcare sector and Drug Manufacturers – Specialty & Generic industry. The company?s Market capitalization was $39.48M with the total Outstanding Shares of 93.66M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: ADMP):

 

Adamis Pharmaceuticals Corporation institutional ownership is standing at 5.5 percent, while insider ownership is 1.3 percent. As of now, ADMP has a P/S, P/E and, P/B values of 2.15, 0, and 1.12 respectively. Its P/Cash is valued at 3.18.

 

The stock SMA50 is now at -48.66 percent. In looking, the SMA 200 we see that the stock has seen a -39.1 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 12 percent.


Profitability ratios:

 

Looking into the profitability ratios of ADMP stock, an investor will find its ROE, ROA, ROI standing at -115.9 percent, -78.5 percent and, -76.9 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 8.52 percent volatile for the week and 8.36 percent for the month.


Gross / Operating Margins of ADMP:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 12 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Adamis Pharmaceuticals Corporation recorded it at $0.


Historical Performance In The News:

 

Taking a look at the performance of Adamis Pharmaceuticals Corporation stock, an investor will come to know that the weekly performance for this stock is valuing at -43.72 percent, resulting in a performance for the month at -56.45 percent.

Therefore, the stated figure displays a quarterly performance of -58.78 percent, bringing six-month performance to -15.16 percent and year to date performance of -42.55 percent. As of now, Adamis Pharmaceuticals Corporation has a P/S, P/E and, P/B values of 2.15, 0, and 1.12 respectively. Its P/Cash is valued at 3.18.


Earnings per Share Details of Adamis Pharmaceuticals Corporation:

 

The EPS of ADMP is strolling at -0.5, measuring its EPS growth this year at 44.9 percent. As a result, the company has an EPS growth of 63.4 percent for the approaching year.